In summary, we show that MYCMI-7 is a direct MYC-binding compound that potently and selectively inhibits MYC:MAX interaction and MYC-mediated gene regulation and tumor cell growth in a MYC-dependent manner in culture and in vivo, while sparing normal cells. The gene discussed is MYC; the disease is neoplasm.